Data / Form D filings / Switch Therapeutics Inc.
Switch Therapeutics Inc.: Form D filings
Switch Therapeutics Inc., a company in South San Francisco, CA, filed 2 Form D notices with the SEC in 2022. The latest, on November 17, 2022, reports $23.3 million sold of a $36 million offering to 15 investors.
Find out what Switch Therapeutics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 241 E HARRIS AVE, South San Francisco, CA, 94080
- Phone
- (415) 518-9678
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1947761
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17, 2022 | Amendment | $35,984,988 | $23,270,993 | $12,713,995 | 15 | Sep 27, 2022 | sec.gov |
| Oct 5, 2022 | New notice | $34,999,989 | $19,870,995 | $15,128,994 | 13 | Sep 27, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin Zhang | Director | |
| Alicia Irurzun-Lafitte | Director | |
| Dylan Morris | Director | |
| Si-Ping Han | Executive Officer | |
| Deepshikha Datta | Executive Officer, Director |
Other companies in California that filed recently
- D'LUX Storage, Inc. $249,993 · Nov 9, 2026
- Ubicloud Inc. $49.6 million · Nov 9, 2026
- Zevia PBC $15 million · Nov 6, 2026
- Series 24-1, a series of StartEngine Private Funds LLC $518,980 · Nov 5, 2026
- PrimePrix Capital Inc $9 million · Nov 5, 2026
- NOVA BOULDERS LLC $621,504 · Nov 5, 2026
- Rasa World Group, Inc. $9.3 million · Nov 5, 2026
- Pelorus Growth Fund, LLC $3.6 million · Nov 5, 2026
- Roq.ad Inc. $10.9 million · Nov 4, 2026
- Series 95-1, a series of StartEngine Private LLC $129,900 · Nov 4, 2026
- CH Common Ground Group LLC $350,000 · Nov 3, 2026
- MoFlo Acquisitions, Inc. $587.5 million · Nov 2, 2026
- BC Movie, LLC offering · Nov 2, 2026
- Jana Education San Jose LLC $200,000 · Nov 2, 2026
- Crosscut SPV Frontier LP - Series 2 $23.4 million · Oct 30, 2026
Every Form D from the week of Nov 14, 2022 · All recent filings in California · All recent Other filings
Read from SEC EDGAR. Amount sold is what Switch Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.